Malignant Peritoneal Neoplasm — Trials

Malignant Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 124
Recruiting: 53
Ph III recruiting: 7
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05080946	Using Aspirin to Improve Immunological Features of Ovarian Tumors	suspended	Early Phase 1	100	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 15, 2026	clinicaltrials
NCT00753480	A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	suspended	Phase 1	56	Genentech, Inc.INDUSTRY	1	Nov 7, 2008	clinicaltrials